Literature DB >> 24915094

Expression, purification, crystallization and preliminary X-ray analysis of the HER3-9E12 Fab complex.

Kecheng He1, Ang Huang2, Yong Huang3, Hiroaki Takeda1.   

Abstract

9E12 is a fully human immunoglobulin G1/κ monoclonal antibody that is specific for the epidermal growth factor receptor 3 (HER3), the overexpression of which has been detected in many tumour types and is associated with poor survival outcomes. To date, knowledge of the molecular mechanism for targeted antibodies that directly inhibit HER3 signalling is limited. Because knowledge of such therapeutic antibodies would help basic immunological therapeutics, structural insights into the HER3-9E12 Fab complex are important. Recombinant human HER3 and Fab fragments of the 9E12 antibody were cloned, expressed and crystallized, and crystallographic data sets were collected. The crystals belonged to space group P1, with unit-cell parameters a=74.4, b=98.6, c=99.6 Å, α=106.0, β=95.0, γ=102.5° and diffracted to a resolution of 2.1 Å.

Entities:  

Keywords:  HER3; targeted therapy

Mesh:

Substances:

Year:  2014        PMID: 24915094      PMCID: PMC4051538          DOI: 10.1107/S2053230X14008917

Source DB:  PubMed          Journal:  Acta Crystallogr F Struct Biol Commun        ISSN: 2053-230X            Impact factor:   1.056


  20 in total

1.  High-affinity human antibodies from phage-displayed synthetic Fab libraries with a single framework scaffold.

Authors:  Chingwei V Lee; Wei-Ching Liang; Mark S Dennis; Charles Eigenbrot; Sachdev S Sidhu; Germaine Fuh
Journal:  J Mol Biol       Date:  2004-07-23       Impact factor: 5.469

2.  Antigenic homology between rat sperm tail polypeptides and Sertoli cell secretory proteins.

Authors:  M Abdullah; L L Tres; H Ueda; P C Hu; A L Kierszenbaum
Journal:  Mol Cell Biochem       Date:  1988-06       Impact factor: 3.396

3.  Epitope characterization and crystal structure of GA101 provide insights into the molecular basis for type I/II distinction of CD20 antibodies.

Authors:  Gerhard Niederfellner; Alfred Lammens; Olaf Mundigl; Guy J Georges; Wolfgang Schaefer; Manfred Schwaiger; Andreas Franke; Kornelius Wiechmann; Stefan Jenewein; Jerry W Slootstra; Peter Timmerman; Annika Brännström; Frida Lindstrom; Ekkehard Mössner; Pablo Umana; Karl-Peter Hopfner; Christian Klein
Journal:  Blood       Date:  2011-03-28       Impact factor: 22.113

4.  Enhancement of metastatic properties of pancreatic cancer cells by MUC1 gene encoding an anti-adhesion molecule.

Authors:  S Satoh; Y Hinoda; T Hayashi; M D Burdick; K Imai; M A Hollingsworth
Journal:  Int J Cancer       Date:  2000-11-15       Impact factor: 7.396

5.  Overexpression of c-erbB-3 in various stages of human squamous cell carcinomas.

Authors:  T Funayama; T Nakanishi; K Takahashi; S Taniguchi; M Takigawa; T Matsumura
Journal:  Oncology       Date:  1998 Mar-Apr       Impact factor: 2.935

6.  All EGF(ErbB) receptors have preformed homo- and heterodimeric structures in living cells.

Authors:  Rong-Hua Tao; Ichi N Maruyama
Journal:  J Cell Sci       Date:  2008-09-09       Impact factor: 5.285

7.  Cetuximab for the treatment of colorectal cancer.

Authors:  Derek J Jonker; Chris J O'Callaghan; Christos S Karapetis; John R Zalcberg; Dongsheng Tu; Heather-Jane Au; Scott R Berry; Marianne Krahn; Timothy Price; R John Simes; Niall C Tebbutt; Guy van Hazel; Rafal Wierzbicki; Christiane Langer; Malcolm J Moore
Journal:  N Engl J Med       Date:  2007-11-15       Impact factor: 91.245

8.  Structure of Nectin-2 reveals determinants of homophilic and heterophilic interactions that control cell-cell adhesion.

Authors:  Dibyendu Samanta; Udupi A Ramagopal; Rotem Rubinstein; Vladimir Vigdorovich; Stanley G Nathenson; Steven C Almo
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-27       Impact factor: 11.205

9.  Comparison of the inhibition mechanisms of adalimumab and infliximab in treating tumor necrosis factor α-associated diseases from a molecular view.

Authors:  Shi Hu; Shuaiyi Liang; Huaizu Guo; Dapeng Zhang; Hui Li; Xiaoze Wang; Weili Yang; Weizhu Qian; Sheng Hou; Hao Wang; Yajun Guo; Zhiyong Lou
Journal:  J Biol Chem       Date:  2013-08-13       Impact factor: 5.157

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.